Michelle M. Dugan, MD

Research Fellow
Cutaneous Oncology Department, Moffitt Cancer Center, Tampa, FL, United States

Presentation(s):

• 64: Hepatic and Overall Progression-Free Survival after Percutaneous Hepatic Perfusion as First-Line or Second-Line Therapy for Metastatic Uveal Melanoma

  Thursday, March 21, 2024
  2:37pm – 2:47pm ET

• P58: Isolated Limb Infusion for Limb Threatening Sarcomas

  Friday, March 22, 2024
  10:31am – 10:37am ET

• 30: Impact of Social Determinants of Health on Melanoma Nodal Surveillance in a Multi-Institutional Cohort

  Saturday, March 23, 2024
  8:02am – 8:12am ET